Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiao Jiedu Granules is a Traditional Chinese Medicine (TCM) formulation based on the classic Yin Qiao San prescription, primarily used for the treatment of the common cold and influenza. It is specifically indicated for wind-heat type respiratory infections characterized by symptoms such as fever, headache, cough, and sore throat. The formulation is manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical and is marketed as an over-the-counter (OTC) product in China. The granules are composed of several botanical extracts, including *Lonicera japonica* (honeysuckle) and *Forsythia suspensa*, which are traditionally recognized for their heat-clearing and detoxifying properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinqiao Jiedu Granules.